Sherman, Shany, et al. “IL-17A Inhibitor Switching – Efficacy of Ixekizumab Following Secukinumab Failure. A Single-Center Experience”. Acta Dermato-Venereologica, vol. 99, no. 9, May 2019, pp. 769-73, doi:10.2340/00015555-3200.